Evaluate the Efficacy and Safety of GZR33 Injection in Patients With Type 2 Diabetes

A Trial of INS068 in Patients With Type 2 Diabetes Not Adequately Controlled With One or Two Oral Antidiabetics

NCT04663282 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety of THDB0206 Compared to Insulin Lispro Injection in Participants With Type 1 Diabetes

NCT07282054 ·Status: COMPLETED ·Phase: PHASE3

A Study of Tirzepatide (LY3298176) Versus Insulin Degludec in Participants With Type 2 Diabetes

NCT03882970 ·Status: COMPLETED ·Phase: PHASE3

Investigating the Safety and Effectiveness of Insulin Degludec in a Real World Population With Type 1 and 2 Diabetes Mellitus

NCT02392117 ·Status: COMPLETED

In-patient Study With GSK716155 In Patients With Type 2 Diabetes Mellitus

NCT00354536 ·Status: COMPLETED ·Phase: PHASE2

A Research Study, Looking at How Tresiba® Works in People With Type 2 Diabetes in Local Clinical Practice in Saudi Arabia

NCT03785522 ·Status: COMPLETED

A Study of Tirzepatide (LY3298176) in Healthy Participants and Participants With Type 2 Diabetes (T2DM)

NCT02759107 ·Status: COMPLETED ·Phase: PHASE1

A Clinical Study to Compare the Bioavailability of HR17031 in Healthy Subjects at Different Sites

NCT06086912 ·Status: COMPLETED ·Phase: PHASE1

A Non-interventional, Post Marketing Surveillance (PMS) Study of Tresiba® (Insulin Degludec) to Evaluate Long Term Safety and Efficacy in Patients With Diabetes Mellitus in Routine Clinical Practice in India

NCT02117622 ·Status: COMPLETED

Injection Site Study In Patients With Type 2 Diabetes Mellitus (T2DM) And Healthy Volunteers

NCT00394030 ·Status: COMPLETED ·Phase: PHASE1

First Time in Human Study Using GSK2330672

NCT01416324 ·Status: COMPLETED ·Phase: PHASE1

A Research Study Comparing How Well Different Doses of the Medicine NN0519-0130 Lower Blood Sugar in People With Type 2 Diabetes

NCT06326047 ·Status: COMPLETED ·Phase: PHASE2

Effect of Retatrutide Compared With Placebo in Participants With Type 2 Diabetes and Moderate or Severe Renal Impairment, With Inadequate Glycemic Control on Basal Insulin, With or Without Metformin and/or SGLT2 Inhibitor (TRANSCEND-T2D-3)

NCT06297603 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

The Efficacy and Safety of Insulin Degludec/Liraglutide Combination (IDegLira) in Patients With Type 2 Diabetes

NCT06408532 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4

A Study to Evaluate Safety and Effectiveness in Patients of All Age Groups Excluding Less Than 12 Months Old Infants With Diabetes Mellitus in Routine Clinical Practice in Korea

NCT02779413 ·Status: COMPLETED

A Study of LY3938577 in Participants With Type 2 Diabetes Previously Treated With Basal Insulin

NCT07215312 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Effect of Retatrutide Compared With Semaglutide in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Metformin With or Without SGLT2 Inhibitor (TRANSCEND-T2D-2)

NCT06260722 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

A Study of LY3938577 in Healthy Participants and Participants With Type 1 Diabetes Mellitus (T1DM)

NCT06280703 ·Status: RECRUITING ·Phase: PHASE1

Post-Marketing Surveillance Study: 12 To 24 Weeks Study On The Treatment Emergent Adverse Events In Patients With Type 2 Diabetes Taking Exenatide In Korea

NCT02090673 ·Status: COMPLETED

Study of the Efficacy and Safety of Inhaled Technosphere Insulin in Patients With Type 2 Diabetes

NCT00511602 ·Status: COMPLETED ·Phase: PHASE2

To Investigate the Blood Concentration of Liraglutide as Well as the Effects on Glucose and Insulin After 21 Days of Daily Subcutaneous Injections of Liraglutide or Placebo

NCT00761540 ·Status: COMPLETED ·Phase: PHASE1

A Research Study to See How Well Weekly Insulin Icodec Maintains Blood Sugar Levels Compared to Daily Basal Insulins in Adults With Type 2 Diabetes

NCT07112339 ·Status: RECRUITING ·Phase: PHASE4

Effect of Short-Term Intensive Insulin Sequential Exenatide Therapy in Newly Diagnosed Type 2 Diabetic Patients

NCT01776788 ·Status: COMPLETED ·Phase: PHASE4

A Pilot Study Investigating Bioequivalence Between a Single Dose of Formulation 2 and Formulation 3 of MEDI0382

NCT03341013 ·Status: COMPLETED ·Phase: PHASE1

Study to Evaluate the Efficacy and Safety of Exenatide Once-Weekly Injection Compared to Once-Daily Insulin in Type 2 Diabetes Mellitus

NCT00935532 ·Status: COMPLETED ·Phase: PHASE3